The Precision Peptide Company Inc.

Recent News

The Precision Peptide Company Wins TikTok Shop Approval as Platform Tightens Peptide Rules, Putting U.S.-Made Peptide Products in Front of 53 Million American Buyers

Highlights Approved TikTok Shop storefront: The Company has been approved to operate its own TikTok Shop in the United States, giving it a direct sales channel to more than 53 million U.S. buyers. Approved under tighter rules: The approval follows TikTok's October 2026 move to restrict searches for several peptide names and its stated prohibition on marketing high-risk products. Rollout underway: The first product is live, with further products from the Company's U.S.-made range being brought...

2026-11-19 7:00 AM EST

The Precision Peptide Company Launches Free Shipping to All 50 States on Its U.S.-Made Over-the-Counter Range

Highlights Free shipping to all 50 U.S. states on every product in the Company's over-the-counter range, effective immediately Seven products, three formats: five capsules (BPC, KPV, Ageless, Chill and Blue), a copper-peptide topical serum (Hair) and the Recovery Patch: no needle, no mixing, no measuring, no refrigeration No prescription required: the range is available to order directly from a dedicated storefront at store.precisionpep.co Made in the United States and third-party tested,...

2026-11-17 7:00 AM EST

The Precision Peptide Company Highlights a Landmark Year and Outlines 2027 Growth Priorities

Highlights U.S. platform built and live: 503A compounding agreement, prescription and telehealth infrastructure, LegitScript Healthcare Merchant Certification and a consumer-facing website now serving all 50 U.S. states Three formats, one brand: 16 clinician-prescribed therapies across seven therapy areas, plus a seven-product over-the-counter range of capsules, a topical serum and the needle-free Recovery Patch Four-patch needle-free line under exclusive manufacturing rights: BPC-157 on sale...

2026-11-11 7:00 AM EST

The Precision Peptide Company Moves Early on New Federal Peptide Policy, Adding All Six Covered Peptides to Its Prescription Platform

Highlights All six peptides covered by the new HHS policy being added: BPC-157, Epitalon, KPV, MOTS-c, Semax and TB-500 are being added to the Company's prescription platform, with availability to patients expected in November 2026 Underway within a week of publication: the Company began adding all six peptides within a week of the policy's publication in the Federal Register on October 30, 2026 Built to the policy's standards: each peptide will be prescribed as a single-ingredient compounded...

2026-11-05 7:00 AM EST

The Precision Peptide Company's Needle-Free First Strategy Already in Place as HHS Draft Policy Recognizes Non-Injectable Routes for Leading Peptides

Highlights Federal path for BPC-157: HHS has published a draft Enforcement Discretion Policy concerning a potential interim 503A compounding path for six peptides: BPC-157, Epitalon, KPV, MOTS-c, Semax and TB-500 Needle-free routes recognized: oral and topical forms for BPC-157 and KPV, and intranasal use for Semax, now sit alongside injection in federal policy Built for the Company's model: the Policy runs through 503A compounding, a similar U.S. pathway behind the Company's 16-therapy...

2026-11-03 7:00 AM EST

The Precision Peptide Company Quadruples U.S. Telehealth Formulary to 16 Prescription Therapies Across Seven Therapy Areas

Highlights Prescription formulary grows from 4 to 16 therapies in under 4 months since the Company's nationwide telehealth launch Seven therapy areas now covered: weight management, performance and growth hormone support, recovery, longevity and cellular health, immune support, cognitive health and sexual wellness Multi-therapy stacked protocols introduced, allowing clinicians to combine therapies into a single personalized program The Company's total portfolio now stands at 23 products...

2026-10-29 7:00 AM EDT

The Precision Peptide Company Highlights 30 Years of Peptide Science Behind Its Product Platform

Vancouver, British Columbia--(Newsfile Corp. - October 28, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), a publicly traded wellness company focused on advanced peptide formulation

2026-10-28 7:00 AM EDT

The Precision Peptide Company Locks In Exclusive Manufacturing Rights Across Its Needle-Free Line

Highlights Exclusive manufacturing rights secured for all four of the Company's patch formulations: BPC-157, Thymosin Alpha-1 (TA1), tirzepatide and GLP3 Four patches, one U.S. manufacturer, one brand: each patch produced solely for The Precision Peptide Company The Recovery Patch (BPC-157) is on sale now; 20,000 TA1 patches ordered, with delivery expected in January 2027 No needle, no mixing, no measuring, no refrigeration 100% manufactured and tested in the United States

2026-10-22 7:00 AM EDT

The Precision Peptide Company Begins Development of GLP3 Patch, Its Fourth Needle-Free Peptide

Needle-free line grows to four U.S.-made patches in a peptide market projected to reach US$87.21 billion by 2035 1 Highlights GLP3 transdermal patch enters development in the United States, the fourth product in the Company's needle-free peptide patch line GLP3 is the Company's second patch in the metabolic and weight-management category, following tirzepatide The Recovery Patch (BPC-157) is on sale now; 20,000 Thymosin Alpha-1 patches ("TA1") ordered, with delivery expected in January 2027...

2026-10-20 7:00 AM EDT

The Precision Peptide Company Advances Needle-Free GLP-1 Tirzepatide Patch into Formal U.S. Testing

Vancouver, British Columbia--(Newsfile Corp. - October 13, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), a publicly traded wellness c

2026-10-13 7:00 AM EDT

RETRANSMISSION: The Precision Peptide Company Orders 20,000 Thymosin Alpha-1 Patches for Commercial Launch

Vancouver, British Columbia--(Newsfile Corp. - October 8, 2026) - Th

2026-10-08 8:00 AM EDT

The Precision Peptide Company Orders 20,000 Thymosin Alpha-1 Patches for Commercial Launch

Vancouver, British Columbia--(Newsfile Corp. - October 7, 2026) - Th

2026-10-07 1:38 PM EDT

The Precision Peptide Company Expands U.S. Wholesale Program, Opening Distribution of Its Needle-Free Range to Clinics, Med Spas, Gyms and Retailers

Vancouver, British Columbia--(Newsfile Corp. - September 29, 2026) - The Precision Peptide Company (CSE: BPC) (OTC

2026-09-29 7:00 AM EDT

The Precision Peptide Company Becomes Strategic Sponsor of Championing Mental Health 3 Boxing Event

Vancouver, British Columbia--(Newsfile Corp. - September 22, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), a publicly traded wellness

2026-09-22 7:00 AM EDT

The Precision Peptide Company Announces Sponsorship of Boulderthon, Boulder Colorado's Marathon Weekend

Highlights Boulderthon 2026 takes place on Sunday, September 27, 2026, in Boulder, Colorado, finishing on the historic Pearl Street Mall.1 According to race organizers, the event welcomed over 15,600 runners in 2025, a 56 percent increase over the prior year, drawing runners from all 50 states and 22 countries.3 Boulderthon is a Boston Marathon Qualifying, USATF Sanctioned event named Top 10 in America by USA Today and among the Best Fall Marathons by Runner's World.1, 3 BPC plans an on-site...

2026-09-15 7:00 AM EDT

The Precision Peptide Company Announces Digital Marketing and Advertising Services Agreements

Vancouver, British Columbia--(Newsfile Corp. - September 10, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC") is pleased to announce that it has entered into agreements with (i) Senergy Communications Capital Inc. ("Senergy") and (ii) 1000903966 Ontario Inc., d.b.a. Komcore Capital ("Komcore"), to provide certain digital marketing and advertising services to the Company. Senergy The Company has entered into a digital marketing services agreement with...

2026-09-10 7:00 AM EDT

The Precision Peptide Company Advances Thymosin Alpha-1 Patch into Formal U.S. Testing

Vancouver, British Columbia--(Newsfile Corp. - September 8, 2026) - The Precision Peptide Company Inc. (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), a publicly traded wellness

2026-09-08 7:00 AM EDT

The Precision Peptide Company Announces Grants of RSUs and Stock Options

Vancouver, British Columbia--(Newsfile Corp. - September 4, 2026) - The Precision Peptide Company Inc. (CSE: BPC) (OTCQB: PNGAF) (the "Company") announces that on July 31, 2026, it has authorized the grant of restricted share units (the "RSUs") and incentive stock options (the "Options") pursuant to the Company's omnibus share incentive plan (the "Plan"). The Company has granted 150,000 RSUs and 200,000 Options to a certain consultant of the Company. Each Option entitles the holder to acquire...

2026-09-04 5:00 PM EDT

The Precision Peptide Company to Showcase Its Needle-Free Recovery Patch and Supplement Range at FitExpo Anaheim

Highlights The Company's supplement range, led by The Recovery Patch, will be available for purchase on site at FitExpo Anaheim, August 29 and 30, 2026 A 15% event discount will be available to attendees on purchases at booth 750, Anaheim Convention Center The Recovery Patch, the Company's needle-free transdermal peptide patch, achieved 95.5% chromatographic purity and a quantified 2.02 mg dose per patch in previously announced independent laboratory testing A key member of the Company's...

2026-08-25 7:00 AM EDT

The Precision Peptide Company Inc. Announces Development of Needle-Free Tirzepatide Transdermal Patch

Vancouver, British Columbia--(Newsfile Corp. - August 19, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), a publicly traded wellness company focused on advanced peptide formulations and delivery systems, today announces that the Company is developing a tirzepatide-based transdermal patch delivery system in the United States as an addition to its advancing product lineup. Highlights US$62 to 66 billion global GLP-1 market in 2025, projected to reach...

2026-08-19 7:00 AM EDT

Ready to Announce with Confidence?

Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us